Thread by @IM_Crit_

Randomised clinical trials in cardiogenic shock in the PCI era

Treatment considerations for patients with AMI-cardiogenic shock

Enrolment data for major randomised cardiogenic shock trials (EuroIntervention 2021; 17: 451-65)

Determination of the Society for Cardiovascular Angiography and Intervention (SCAI) Shock stage using the revised SCAI Shock Classification

Conceptual model showing the overlap between
different states of hemodynamic compromise. Shock is defined by presence of hypoperfusion; most, but NOT ALL, patients will also be hypotensive. Pts w hemodynamic instability who do not meet criteria for shock are labeled as pre-shock

Management algorithm for patients with or at risk for cardiogenic shock (CS) tailored to the Society for Cardiovascular Angiography and Intervention (SCAI) Shock stage

Framework of clinical parameters to follow in patients with heart failure-related cardiogenic shock in the critical care unit

Considerations for invasive hemodynamic assessment in HF-CS

Classification and management of HF-CS

#FOAMed #FOAMcc #MedTwitter #MedEd #MedStudentTwitter

It seems that the most controversial issue is the use of short-term mechanical circulatory support for cardiogenic shock. So, a very recent publication deals with this:

Proposed overview of selection of patients to pVAD based on SCAI shock class A-E

Flowchart to identify and handle potential need for escalation of mechanical circulatory support in patients supported by axial flow pump (AFP)

Flowchart to identify and handle potential need for venting during V-A ECMO support